Invesco Health Care Fund Q4 2024 Commentary
Source: SeekingAlpha
2025-03-20 09:05:00 ET
Summary
- Stock selection in life science tools & services, pharmaceuticals and distributors detracted from relative performance, as did an overweight in health care facilities.
- The health care sector underperformed all US stock market sectors except materials during the quarter.
- Headwinds for health care include weak China demand dragging on the life sciences tools and services industry and hospitals facing negative sentiment tied to anticipated Trump policy and potentially lower reimbursement revenue.
...
Read the full article on Seeking Alpha
For further details see:
Invesco Health Care Fund Q4 2024 Commentary
Janux Therapeutics Inc.
NASDAQ: JANX
JANX Trading
-0.68% G/L:
$14.64 Last:
514,387 Volume:
$14.74 Open:
JANX Latest News
May 07, 2026 04:01:00 pm
Janux Therapeutics Reports First Quarter 2026 Financial Results and Business Highlights
April 27, 2026 04:01:00 pm
Janux Therapeutics Announces Discontinuation of JANX008 Clinical Development
April 16, 2026 04:01:00 pm
Janux Therapeutics Announces First Participant Dosed in Phase 1 Study of JANX014
JANX Stock Data
$789,139,228
45,531,890
1.75%
55
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
